Sign in Subscribe
9 min read EMA10 - EMA30 Crossover

EverHint – EMA10 × EMA30 Crossover Signals for Feb 03, 2026 – Healthcare Leads with 11 Setups

60 signals. Healthcare leads (11). 13 with insider selling. 3 with insider buying. price range $5-$759. RSI 18-86. sectors: Healthcare (11), Financial Services (10), Technology (10). 7 report earnings within 7 days. full analyst coverage, 33.3% have news.

What This Signal Is (Quick)

This strategy detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30):

  • Buy Signal (EMA10_x_EMA30_Buy): EMA(10) crosses above EMA(30) on today's close

    • Short-term momentum overtakes medium-term trend
    • Suggests acceleration in upward price movement
    • Ideal for swing trading (1-4 week holding periods)

  • Sell Signal (EMA10_x_EMA30_Sell): EMA(10) crosses below EMA(30) on today's close

    • Short-term momentum weakens below medium-term trend
    • Suggests deceleration or reversal of upward movement
    • Can signal exit points or short entry opportunities

Key Characteristics:

  • Uses two EMAs (both exponential) for faster response to price changes
  • More responsive than EMA10 x SMA50, generating more frequent signals
  • Better suited for capturing short-to-medium term momentum shifts
  • Higher sensitivity means more signals but also higher whipsaw risk in choppy markets

Key Criteria:

  • Buy: EMA10 crosses above EMA30

  • Sell: EMA10 crosses below EMA30

  • Minimum ADV: $40M (liquidity filter)

  • Earnings buffer: 7 days pre/post earnings

  • Fresh crossover: Detected on today's close

Holding Period: 1-4 weeks
Risk Level: Medium

How We Ranked Today

Ranked by RSI (lower RSI for buy signals = more oversold)

📈 Buy-Side Signals (23 Total)

Ranked by RSI (lower RSI for buy signals = more oversold):

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 PACS PACS Group, Inc. Healthcare 36.78 28.2 — — $2.45 5.7
2 MTH Meritage Homes Corpora... Consumer Cyclical 72.77 34.7 — 77 $9.40 5.1
3 FUL H. B. Fuller Company Basic Materials 63.06 40.3 — 49 $5.78 3.4
4 REGN Regeneron Pharmaceutic... Healthcare 759.18 50.1 — 83 $67.70 78.4
5 VNT Vontier Corporation Technology 38.77 51.1 — 85 $0.00 5.6
6 CRS Carpenter Technology C... Industrials 338.92 57.3 $-865K 78 $15.40 16.9
7 JAZZ Jazz Pharmaceuticals plc Healthcare 166.84 57.6 $-10.0M 90 $31.42 10.1
8 PNFP Pinnacle Financial Par... Financial Services 99.00 58.5 $-630K — $8.62 7.6
9 COLM Columbia Sportswear Co... Consumer Cyclical 57.40 59.0 — 85 $4.03 3.1
10 DAY Dayforce, Inc. Technology 69.86 60.3 — 1 $4.37 11.2
11 CNK Cinemark Holdings Inc ... Communication Services 24.68 63.1 — 86 $2.68 2.9
12 KR Kroger Company (The) Consumer Defensive 64.17 63.1 — 30 $6.06 42.5
13 AMX America Movil, S.A.B. ... Communication Services 21.76 64.6 — 83 $0.00 65.5
14 BXMT Blackstone Mortgage Tr... Real Estate 19.79 66.3 — 84 $2.02 3.4
15 MPC Marathon Petroleum Cor... Energy 187.58 66.5 — 90 $29.20 56.4
16 TERN Terns Pharmaceuticals,... Healthcare 38.52 67.4 $-3.0M 44 $-1.23 3.5
17 ESTA Establishment Labs Hol... Healthcare 73.34 68.7 $-163K 22 $1.57 2.1
18 MSM MSC Industrial Direct ... Industrials 91.18 69.0 $+2.5M 57 $4.85 5.1
19 HIG Hartford Financial Ser... Financial Services 138.44 70.1 — 78 $16.05 38.6
20 QURE uniQure N.V. Healthcare 27.80 70.2 — 23 $2.15 1.7
21 L Loews Corporation Financial Services 107.41 75.6 — 90 $0.00 22.2
22 TRV The Travelers Companie... Financial Services 288.23 82.7 — — $28.59 64.3
23 DVA DaVita Inc. Healthcare 134.73 85.7 — 9 $18.12 9.5

📉 Sell-Side Signals (Top 25 of 37 total)

Ranked by RSI (higher RSI for sell signals = more overbought):

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 KNSL Kinsale Capital Group,... Financial Services 391.77 58.7 — 78 $22.95 9.1
2 AMT American Tower Corpora... Real Estate 173.13 48.8 — 83 $9.25 81.1
3 RITM Rithm Capital Corp. Real Estate 10.95 45.8 $-3.3M 79 $2.53 6.1
4 BHF Brighthouse Financial,... Financial Services 63.68 44.7 — 7 $20.95 3.6
5 CTRE CareTrust REIT, Inc. Real Estate 36.68 44.0 — 85 $1.58 7.1
6 NG Novagold Resources Inc. Basic Materials 9.16 42.8 — 55 $-0.04 3.7
7 LLYVK Liberty Media Corporat... Communication Services 81.00 42.7 — 23 $3.60 7.4
8 LAC Lithium Americas Corp. Basic Materials 5.17 42.1 — 52 $0.18 1.2
9 PRKS United Parks & Resorts... Consumer Cyclical 34.92 39.7 $-253K 22 $4.48 1.9
10 AS Amer Sports, Inc. Consumer Cyclical 35.95 39.3 — 21 $2.13 19.9
11 LINE Lineage, Inc. Real Estate 35.10 38.5 $+3.3M 84 $-0.17 8.0
12 COO The Cooper Companies, ... Healthcare 79.33 38.3 — 30 $6.09 15.8
13 UPWK Upwork Inc. Communication Services 18.25 38.0 $-3.9M 90 $2.31 2.4
14 GLOB Globant S.A. Technology 58.09 37.8 — 16 $7.15 2.6
15 DXC DXC Technology Company Technology 13.50 37.0 — 0 $3.65 2.4
16 TXT Textron Inc. Industrials 88.63 36.9 — 78 $8.94 15.6
17 NTRA Natera, Inc. Healthcare 227.68 36.7 $-56.8M 23 $2.68 31.5
18 SEDG SolarEdge Technologies... Technology 30.97 36.2 — 90 $3.70 1.9
19 TMO Thermo Fisher Scientif... Healthcare 570.09 34.7 — 77 $36.24 214.2
20 PJT PJT Partners Inc. Financial Services 160.62 34.4 — 83 $11.03 3.9
21 PNR Pentair plc. Industrials 94.79 34.3 — 76 $6.50 15.5
22 WEX WEX Inc. Technology 144.28 33.7 $-300K 84 $21.77 4.9
23 BAH Booz Allen Hamilton Ho... Industrials 83.00 33.4 — — $6.88 10.2
24 FOXA Fox Corporation Communication Services 70.27 33.2 — 0 $4.61 31.7
25 EPAM EPAM Systems, Inc. Technology 183.33 32.4 — 16 $15.06 10.1

Field Notes

Sector concentration: Healthcare (11), Financial Services (10), Technology (10)

Insider selling: NTRA (Natera, Inc., $-56.8M), EA (Electronic Arts Inc., $-4.7M), TERN (Terns Pharmaceuticals, Inc., $-3.0M)

Insider buying: WMG (Warner Music Group Corp., $+998K), MSM (MSC Industrial Direct Company,, $+2.5M), LINE (Lineage, Inc., $+3.3M)

Near-term earnings: BHF (Brighthouse Financial, Inc.), CPAY (Corpay, Inc.), DAY (Dayforce, Inc.), DOX (Amdocs Limited), DXC (DXC Technology Company), FOXA (Fox Corporation), WMG (Warner Music Group Corp.) report within 7 days. Higher volatility risk.

Data coverage: 26.7% insider, 1.7% congressional (1 recent/90d), 91.7% earnings, 100.0% analyst, 33.3% news

Congressional Activity

LLYVK (Liberty Media Corporation - Ser) ⚪ Neutral (90d)

Recent Headlines

AMT (American Tower Corporation (REI)

  • Heritage Investors Management Corp Acquires 5,142 Shares of American Tower Corporation $AMT (source)
  • Jones Financial Companies Lllp Raises Stock Holdings in American Tower Corporation $AMT (source)
  • Bridges Investment Management Inc. Lowers Stock Position in American Tower Corporation $AMT (source)
  • National Pension Service Grows Holdings in American Tower Corporation $AMT (source)
  • Principal Financial Group Inc. Sells 98,820 Shares of American Tower Corporation $AMT (source)
  • Key Themes To Watch This REIT Earnings Season (source)
  • Ballentine Partners LLC Lowers Stock Position in American Tower Corporation $AMT (source)
  • Alpha Cubed Investments LLC Has $45.69 Million Holdings in American Tower Corporation $AMT (source)
  • Bank of New York Mellon Corp Sells 31,358 Shares of American Tower Corporation $AMT (source)
  • Federated Hermes Inc. Sells 40,704 Shares of American Tower Corporation $AMT (source)
  • American Tower Plans Fourth Quarter and Full Year 2025 Earnings Release and Conference Call (source)

AS (Amer Sports, Inc.)

  • Amer Sports Announces Redemption of $80 Million of 6.750% Senior Secured Notes Due 2031 and Announces Earnings Date (source)

BAH (Booz Allen Hamilton Holding Cor)

  • Defense Tech Stocks Move Higher as $15 Billion Cyber Budget Targets Quantum Threats (source)

BHF (Brighthouse Financial, Inc.)

  • Brighthouse Financial, Inc. (NASDAQ:BHF) Given Average Rating of “Reduce” by Brokerages (source)

BXMT (Blackstone Mortgage Trust, Inc.)

  • High-Yield Carnage In 2026 (source)
  • Key Themes To Watch This REIT Earnings Season (source)

CTRE (CareTrust REIT, Inc.)

  • CareTrust REIT Sets Fourth Quarter Earnings Call for Friday, February 13, 2026 (source)

PNFP (Pinnacle Financial Partners, In)

  • 1 Bank Stock Set to Rebound in 2026 (source)
  • Pinnacle Financial Partners Announces Preferred Stock Dividends (source)

PNR (Pentair plc.)

  • Pentair plc (PNR) Q4 2025 Earnings Call Transcript (source)
  • Pentair (PNR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (source)
  • Pentair plc (PNR) Beats Q4 Earnings and Revenue Estimates (source)
  • Pentair Announces New Executive Leadership Roles to Accelerate Growth and Enhance Customer Focus (source)
  • Pentair Reports Strong Fourth Quarter and Full Year 2025 Results (source)
  • Truist Financial Corp Has $6.49 Million Position in Pentair plc $PNR (source)
  • Pentair Gears Up to Report Q4 Earnings: What to Expect From the Stock? (source)
  • Bank of New York Mellon Corp Has $107.80 Million Stock Holdings in Pentair plc $PNR (source)

PRKS (United Parks & Resorts Inc.)

  • Busch Gardens Unveils a Thrilling Live Music Series for 2026, Featuring the Strongest Lineup in Series History with Over 25 Concerts (source)

QURE (uniQure N.V.)

  • QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (source)
  • QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (source)

REGN (Regeneron Pharmaceuticals, Inc.)

  • These Analysts Revise Their Forecasts On Regeneron Pharmaceuticals After Q4 Results (source)
  • EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases (source)
  • Great Lakes Advisors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN (source)
  • Regeneron: Expect Double-Digit Growth In 2026 (source)
  • Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (source)
  • Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call Transcript (source)
  • Regeneron bets added cholesterol benefit will help its obesity drug stand out (source)
  • Regeneron (REGN) Reports Q4 Earnings: What Key Metrics Have to Say (source)
  • REGN Q4 Earnings Beat Estimates, Sales Rise on Eylea HD Growth (source)
  • Regeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory (source)
  • Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates (source)
  • First Look: Fed pick, Apple iPhone boom, Tesla pivot, metals swing (source)
  • Regeneron beats quarterly profit estimates on Dupixent strength (source)
  • Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (source)
  • Bank of New York Mellon Corp Acquires 15,006 Shares of Regeneron Pharmaceuticals, Inc. $REGN (source)
  • Regeneron Pharmaceuticals Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call (source)
  • Will Higher Dupixent Profits, Eylea HD Sales Drive REGN's Q4 Earnings? (source)
  • Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Cullen Frost Bankers Inc. (source)

RITM (Rithm Capital Corp.)

  • Rithm Capital Corp. (RITM) Q4 2025 Earnings Call Transcript (source)
  • KBRA Assigns Preliminary Ratings to New Residential Mortgage Loan Trust 2026-NQM2 (NRMLT 2026-NQM2) (source)
  • Compared to Estimates, Rithm (RITM) Q4 Earnings: A Look at Key Metrics (source)
  • Rithm (RITM) Surpasses Q4 Earnings and Revenue Estimates (source)
  • Rithm Capital Corp. Announces Fourth Quarter and Full Year 2025 Results (source)
  • Curious about Rithm (RITM) Q4 Performance? Explore Wall Street Estimates for Key Metrics (source)
  • Rithm Capital Deepens Partnership With Valon; AI-Native Platform to Advance Newrez Servicing Capabilities (source)
  • RITM.PR.F: An 8.75% Fixed-Rate Reset Preferred IPO From Rithm Capital (source)
  • Rithm Capital Corp. Announces Treatment of 2025 Taxable Dividends (source)

SEDG (SolarEdge Technologies, Inc.)

  • SolarEdge Technologies (SEDG) Stock Drops Despite Market Gains: Important Facts to Note (source)
  • SolarEdge to Announce Financial Results for the Fourth Quarter and Year Ended December 31, 2025, on Wednesday, February 18, 2026 (source)
  • TAN: Solar Stocks Keep Shining (source)
  • SolarEdge Starts Shipping US-Manufactured Residential Solar Inverter Products to Europe, Unveils Simplified Product Range (source)

TERN (Terns Pharmaceuticals, Inc.)

  • Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (source)

TMO (Thermo Fisher Scientific Inc)

  • Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update) (source)
  • Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results (source)

TRV (The Travelers Companies, Inc.)

  • Travelers: FY2025 Results Reinforce Long-Term Dividend Appeal (source)
  • Travelers and National Trust Take Resilience Initiative to Los Angeles (source)

TXT (Textron Inc.)

  • Textron Elects Cristina Méndez to Board of Directors (source)
  • Bank of New York Mellon Corp Reduces Holdings in Textron Inc. $TXT (source)
  • Why Textron (TXT) is a Top Momentum Stock for the Long-Term (source)
  • Textron Reports Fourth Quarter 2025 Results; Announces 2026 Financial Outlook (source)

Market Context

The broader market exhibited downside pressure on 2026-02-03, with the S&P 500 declining 0.97%, Nasdaq dropping 1.74%, and Dow Jones falling 0.24%. This bearish trend signals waning risk appetite, particularly evident in the sharper Nasdaq pullback, which could challenge ema10/ema30 crossover strategies reliant on short-term momentum. In a downtrending environment, these signals may generate more false positives or whipsaws, as declining indices reduce the reliability of bullish crossovers without broader confirmation.

Elevated volatility, reflected in the VIX surging 11.08% to 17.95, amplifies intraday swings, heightening the risk of rapid reversals that disrupt ema10/ema30 setups. Traders should approach these 60 signals with tighter stops, as heightened VIX levels often lead to exaggerated price action, eroding edge in trend-following systems during uncertain sessions.

Sector rotation favors defensive areas like Healthcare, the top sector amid these declines, suggesting relative strength that could bolster ema10/ema30 signals there. While broad market weakness tempers overall enthusiasm, this rotation implies selective opportunities in resilient pockets, warranting focus on Healthcare for higher conviction trades.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (11 signals) suggests sector-specific rotation. 3 signals with insider buying adds conviction. 13 signals showing insider selling warrant caution. Average RSI of 45 indicates oversold conditions.

Trading tips for this strategy:

  • Entry timing: Enter on pullback after crossover or at crossover close price
  • Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
  • Stop loss: Below recent swing low for buys, above recent swing high for sells
  • Take profit: 5-10% target for swings, or trail stop at EMA10
  • Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)

Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)

Sharing Call-to-Action

✅ If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

Published by:

Vladimir Shamgin

You might also like...

03
Feb

EverHint – SMA20 × SMA50 Crossover Signals for Feb 03, 2026 – Healthcare Leads with 7 Setups

29 signals. Healthcare leads (7). 9 with insider selling. 1 with congressional buying. 1 with congressional selling. price range $6-$4645. RSI 10-76. sectors: Healthcare (7), Consumer Cyclical (5), Technology (4). 1 report earnings within 7 days. full analyst coverage, 51.7% have news.
10 min read
03
Feb

EverHint – EMA10 × Price × MACD Signals for Feb 03, 2026 – Financial Services Leads with 2 Setups

12 signals. Financial Services leads (2). 1 with insider selling. 1 with congressional buying. price range $10-$382. RSI 51-68. sectors: Financial Services (2), Consumer Defensive (2), Industrials (2). 4 report earnings within 7 days. full analyst coverage, 50.0% have news.
4 min read
02
Feb

EverHint – SMA20 × SMA50 Crossover Signals for Feb 02, 2026 – Healthcare Leads with 7 Setups

28 signals. Healthcare leads (7). 7 with insider selling. 1 with congressional selling. price range $6-$364. RSI 1-76. sectors: Healthcare (7), Financial Services (5), Consumer Cyclical (4). 4 report earnings within 7 days. full analyst coverage, 28.6% have news.
5 min read
02
Feb

EverHint – EMA10 × Price × MACD Signals for Feb 02, 2026 – Industrials Leads with 6 Setups

18 signals. Industrials leads (6). 1 with insider selling. 1 with insider buying. price range $8-$384. RSI 38-91. sectors: Industrials (6), Healthcare (4), Consumer Cyclical (3). 4 report earnings within 7 days. full analyst coverage, 33.3% have news.
3 min read
02
Feb

EverHint – EMA10 × EMA30 Crossover Signals for Feb 02, 2026 – Financial Services Leads with 14 Setups

51 signals. Financial Services leads (14). 13 with insider selling. 3 with insider buying. 1 with congressional buying. 2 with congressional selling. price range $2-$511. RSI 21-64. sectors: Financial Services (14), Technology (11), Industrials (8). 6 report earnings within 7 days. 29.4% have news.
9 min read